IE872667L - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
IE872667L
IE872667L IE872667A IE266787A IE872667L IE 872667 L IE872667 L IE 872667L IE 872667 A IE872667 A IE 872667A IE 266787 A IE266787 A IE 266787A IE 872667 L IE872667 L IE 872667L
Authority
IE
Ireland
Prior art keywords
pharmaceutical compositions
synergist
opt
salts
acid
Prior art date
Application number
IE872667A
Original Assignee
Bandag Licensing Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bandag Licensing Corp filed Critical Bandag Licensing Corp
Publication of IE872667L publication Critical patent/IE872667L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Pharmaceutical compsns. for oral admin. comprise (a) a drug whose bioavailability is increased in the presence of an absorption promoter, (b) chenodeoxycholic acid, deoxycholic acid or their salts, (c) a carrier, and opt. (d) a synergist for component (b). [EP0263493A2]
IE872667A 1986-10-07 1987-10-06 Pharmaceutical compositions IE872667L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91615086A 1986-10-07 1986-10-07

Publications (1)

Publication Number Publication Date
IE872667L true IE872667L (en) 1988-04-07

Family

ID=25436780

Family Applications (1)

Application Number Title Priority Date Filing Date
IE872667A IE872667L (en) 1986-10-07 1987-10-06 Pharmaceutical compositions

Country Status (14)

Country Link
EP (1) EP0263493A3 (en)
JP (1) JPS6396138A (en)
CN (1) CN87106855A (en)
AU (1) AU7939487A (en)
DK (1) DK521487A (en)
FI (1) FI874382A (en)
HU (1) HU196903B (en)
IE (1) IE872667L (en)
IL (1) IL84099A0 (en)
MC (1) MC1878A1 (en)
NO (1) NO874193L (en)
PT (1) PT85871B (en)
ZA (1) ZA876930B (en)
ZW (1) ZW18787A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0643315B2 (en) * 1988-01-20 1994-06-08 東京田辺製薬株式会社 Bile acid composition
DD293494A5 (en) * 1989-03-29 1991-09-05 Fahlberg List Gmbh Magdeburg PROCESS FOR PREPARING A GALENIC PREPARATION WITH OPTIMAL BIODEGRADABILITY OF THE ACTIVE 2-HYDROXY-5-METHYLLAURO-PHENONOXIM (HMLO)
CA2033714A1 (en) * 1990-01-25 1991-07-26 Alberto Ferro Pharmaceutical preparations
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US8093207B2 (en) * 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
US8318663B2 (en) 2008-11-26 2012-11-27 Satiogen Pharmaceuticals, Inc. Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent
CN102316872B (en) 2008-11-26 2016-12-21 萨蒂奥根制药公司 Treatment obesity and the bile acid recycling inhibitors of diabetes
EP3593802A3 (en) 2010-05-26 2020-03-25 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
EA201891154A1 (en) 2011-10-28 2019-02-28 ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи INHIBITORS OF BILIC ACID RECYCLING IN THE TREATMENT OF CHOLESTATIC DISEASES OF THE LIVER IN CHILDREN
CN105617353A (en) * 2016-01-04 2016-06-01 李志海 Oral administration composition of colistin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562007A (en) * 1978-11-02 1980-05-10 Fujisawa Pharmaceut Co Ltd Preparation for rectal administration
JPS57158719A (en) * 1981-03-24 1982-09-30 Fujisawa Pharmaceut Co Ltd Rectal administration pharmaceutical
US4760059A (en) * 1985-08-05 1988-07-26 Hoffmann-La Roche Inc. Rectal dosage form

Also Published As

Publication number Publication date
HUT45395A (en) 1988-07-28
ZW18787A1 (en) 1988-05-25
EP0263493A2 (en) 1988-04-13
HU196903B (en) 1989-02-28
CN87106855A (en) 1988-04-20
PT85871B (en) 1990-01-17
NO874193L (en) 1988-04-08
FI874382A (en) 1988-04-08
MC1878A1 (en) 1989-01-24
DK521487A (en) 1988-04-08
JPS6396138A (en) 1988-04-27
FI874382A0 (en) 1987-10-06
NO874193D0 (en) 1987-10-06
EP0263493A3 (en) 1989-06-14
PT85871A (en) 1987-11-01
ZA876930B (en) 1988-05-25
AU7939487A (en) 1988-04-14
DK521487D0 (en) 1987-10-05
IL84099A0 (en) 1988-03-31

Similar Documents

Publication Publication Date Title
AU7960287A (en) Prodrug derivatives of carboxylic acid drugs
AU588202B2 (en) Dosage form for delivering acid sensitive beneficial agent
AU7076887A (en) Nasal administration of drugs
NO863061D0 (en) PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PHENOXYDICOIC ACID DERIVATIVES.
GR3032101T3 (en) Vehicles for oral administration of a specific pharmaceutically active acid labile substance.
NO861956L (en) PROCEDURE FOR THE PREPARATION OF ASCORBIC ACID DERIVATIVES.
NO864425D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HETEROCYCLYLOX OTHALAZINYL ACETIC ACID DERIVATIVES.
IL78942A0 (en) Thiazolidinecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
AU8297787A (en) 1h-imadazole-5-carboxylic acid derivatives
AU8292687A (en) Thiol-carboxylic acid derivatives
IE872667L (en) Pharmaceutical compositions
AU587108B2 (en) Imidazolecarboxylic acid derivatives
AU2228888A (en) Aqueous pharmaceutical preparation for oral administration
IL81179A0 (en) Azine acid derivatives,their preparation and pharmaceutical compositions containing them
IL77849A0 (en) Aryldihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them
AU5948286A (en) Anthranilic acid derivatives
IL84808A0 (en) Furanuronic acid derivatives,their preparation and pharmaceutical compositions containing them
NZ218855A (en) 3-aminoglycosyl-21-amino-14,21-epoxy-24-norcholanic acid lactam derivatives and pharmaceutical compositions
AU5834486A (en) Novel quinoline derivatives, pharmaceutical compositions containing them and process for the preparation thereof
AU553874B2 (en) Thiazaspirane derivatives
IE873212L (en) Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor
DE3881254D1 (en) PHARMACEUTICAL COMPOSITION.
AU8314987A (en) 1-methyl-1h-imidazole-5-carboxylic acid derivatives
IL77799A0 (en) Dihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them
NZ221018A (en) 2-penem-3-carboxylic acid derivatives and pharmaceutical compositions